New Stock News | It is reported that Hummingbird, a biopharmaceutical company, is considering going public in Hong Kong next year.

According to the Wisdom Financial App, biotechnology has become one of the themes in the Hong Kong market. It was reported that Singaporean biopharmaceutical company Hummingbird Bioscience is considering listing in Hong Kong next year.